Acute liver failure secondary prevention: Difference between revisions
(Created page with "__NOTOC__ {{Acute liver failure}} Please help WikiDoc by adding content here. It's easy! Click here to learn about editing. ==References== {{...") |
|||
| (7 intermediate revisions by 4 users not shown) | |||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Acute liver failure}} | {{Acute liver failure}} | ||
{{CMG}} {{AE}} | |||
==Overview== | |||
Effective measures for secondary prevention of acute liver failure include management of chronic liver disease and its complications. In patients with resolved [[hepatitis B]] infection, [[Antiviral Therapy|antiviral prophylaxis]] can be considered in the patients who have a risk of reactivation such as [[immunosuppressed]] individuals. | |||
==Secondary Prevention== | |||
Effective measures for secondary prevention of acute liver failure include:<ref name="pmid27311622">{{cite journal| author=Karvellas CJ, Cardoso FS, Gottfried M, Reddy KR, Hanje AJ, Ganger D et al.| title=HBV-Associated Acute Liver Failure After Immunosuppression and Risk of Death. | journal=Clin Gastroenterol Hepatol | year= 2017 | volume= 15 | issue= 1 | pages= 113-122 | pmid=27311622 | doi=10.1016/j.cgh.2016.06.008 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=27311622 }} </ref> | |||
* Management of [[chronic liver disease]] appropriately. | |||
* Management of active complications of the chronic liver disease. | |||
* In patients with resolved [[hepatitis B infection]], [[antiviral]] [[prophylaxis]] can be considered in the patients who have risk of reactivation such as [[immunosuppressed]] individuals. | |||
==References== | ==References== | ||
{{Reflist|2}} | {{Reflist|2}} | ||
[[Category: | [[Category:Hepatology]] | ||
[[Category:Gastroenterology]] | |||
{{WH}} | |||
{{WS}} | |||
Latest revision as of 18:36, 14 December 2017
|
Acute liver failure Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Acute liver failure secondary prevention On the Web |
|
American Roentgen Ray Society Images of Acute liver failure secondary prevention |
|
Risk calculators and risk factors for Acute liver failure secondary prevention |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief:
Overview
Effective measures for secondary prevention of acute liver failure include management of chronic liver disease and its complications. In patients with resolved hepatitis B infection, antiviral prophylaxis can be considered in the patients who have a risk of reactivation such as immunosuppressed individuals.
Secondary Prevention
Effective measures for secondary prevention of acute liver failure include:[1]
- Management of chronic liver disease appropriately.
- Management of active complications of the chronic liver disease.
- In patients with resolved hepatitis B infection, antiviral prophylaxis can be considered in the patients who have risk of reactivation such as immunosuppressed individuals.
References
- ↑ Karvellas CJ, Cardoso FS, Gottfried M, Reddy KR, Hanje AJ, Ganger D; et al. (2017). "HBV-Associated Acute Liver Failure After Immunosuppression and Risk of Death". Clin Gastroenterol Hepatol. 15 (1): 113–122. doi:10.1016/j.cgh.2016.06.008. PMID 27311622.